Reeve Woods Eye Center — Chico, California

Reeve Woods Eye Center is a clinical research site located in Chico, California, United States 95926.

Crixeo Clinical Trials Trust Score: 13/100 (FAILING). This profile has not yet been claimed by the site owner.

Reeve Woods Eye Center has participated in 3 clinical trials with 1 currently active.

Therapeutic areas: Glaucoma, Aphakia, Cataract.

Sponsors: iSTAR Medical, RxSight, Inc., Aerie Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Chico

Browse all research sites in California · View every site in Chico

• California State University - Chico
• Enloe Medical Center
• Enloe Cancer Center at Enloe Medical Center
• Adventist Health Cancer Care Center Chico
• Enloe Regional Cancer Center
• GSK Investigational Site
• Research Site
• Gregory L. Davis, M.D., FACOG, Inc.
• Dr. Stephen David Forner - 1405 Magnolia Avenue, Suite B
• Feather River Cancer Center
• Research Facility

Sponsor Feasibility Report

Trust Score: 13/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Reeve Woods Eye Center?

Reeve Woods Eye Center has a Crixeo Trust Score of 13/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Reeve Woods Eye Center conducted?

Reeve Woods Eye Center has 3 clinical trials on record, with 1 currently active. Their work covers Glaucoma, Aphakia, Cataract.

Is Reeve Woods Eye Center accredited by Crixeo Clinical Trials?

Reeve Woods Eye Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Reeve Woods Eye Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.